Vascular Disease Prevention

0.2(top 100%)

impact factor

441(top 50%)

papers

529(top 50%)

citations

10(top 50%)

h-index

0.2(top 100%)

extended IF

448

all documents

558

doc citations

17(top 50%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Role of Endothelial Cells in Myocardial Ischemia-Reperfusion Injury	Vascular Disease Prevention	2010	92
2	A Finite Element Analysis Rupture Index (FEARI) as an Additional Tool for Abdominal Aortic Aneurysm Rupture Prediction	Vascular Disease Prevention	2009	25
3	Human Saphenous Vein and Coronary Bypass Surgery: Scanning Electron Microscopy of Conventional and ‘No-Touch’ Vein Grafts	Vascular Disease Prevention	2004	16
4	A Finite Element Analysis Rupture Index (FEARI) as an Additional Tool for Abdominal Aortic Aneurysm Rupture Prediction	Vascular Disease Prevention	2009	15
5	Vasculoprotective Effects of Apolipoprotein Mimetic Peptides: An Evolving Paradigm in HDL Therapy	Vascular Disease Prevention	2009	14
6	Metabolic Syndrome: Clinical Features Leading to Therapeutic Strategies	Vascular Disease Prevention	2004	14
7	Effects of Nicotine on the Cardiovascular System	Vascular Disease Prevention	2005	14
8	Antihypertensive Effect of Sesamin	Vascular Disease Prevention	2004	13
9	Vasculoprotective Effects of Apolipoprotein Mimetic Peptides: An Evolving Paradigm in HDL Therapy	Vascular Disease Prevention	2009	12
10	L-Arginine Availability as a Pathological Mechanism in Essential Hypertension, Chronic Renal and Heart Failure	Vascular Disease Prevention	2005	10
11	Antihypertensive Effect of Sesamin	Vascular Disease Prevention	2008	10
12	Prevention of Cardiovascular Complications in the Marfan Syndrome	Vascular Disease Prevention	2004	9
13	Preventing Vascular Graft Failure: Endothelial Cell Seeding and Tissue Engineering	Vascular Disease Prevention	2005	8
14	Insights into the Pathogenesis and Intervention of Atherosclerosis	Vascular Disease Prevention	2008	7
15	Guidelines and their Implementation: A Discussion Document Focused on the Best Approaches to Drive Improvement	Vascular Disease Prevention	2004	7
16	Involvement of Cytokines and Inflammation in Catecholamine-Induced Pulmonary Injury in Rats	Vascular Disease Prevention	2005	7
17	Neuroprotection by Diazoxide in Animal Models for Cerebrovascular Disorders	Vascular Disease Prevention	2006	6
18	Motion Analysis of the Carotid Artery Wall and Plaque Using B-Mode Ultrasound	Vascular Disease Prevention	2007	6
19	C6-Ceramide-Coated Catheters Promote Re-Endothelialization of Stretch- Injured Arteries	Vascular Disease Prevention	2008	6
20	Benefits of Exercise Training in Secondary Prevention of Coronary and Peripheral Arterial Disease	Vascular Disease Prevention	2008	6
21	Fibrin Clot Properties and Cardiovascular Disease	Vascular Disease Prevention	2006	6
22	The Potential Roles of Gamma-Glutamyltransferase Activity in the Progression of Atherosclerosis and Cardiovascular Diseases	Vascular Disease Prevention	2006	5
23	Benefits of Exercise Training in Secondary Prevention of Coronary and Peripheral Arterial Disease	Vascular Disease Prevention	2008	5
24	C6-Ceramide-Coated Catheters Promote Re-Endothelialization of Stretch- Injured Arteries	Vascular Disease Prevention	2008	5
25	Novel Strategies in Anti-Platelet Treatment for Coronary Artery Disease	Vascular Disease Prevention	2009	5
26	Carotid Ultrasound in One, Two and Three Dimensions	Vascular Disease Prevention	2005	5
27	Prognostic Value of Coronary Artery Calcification	Vascular Disease Prevention	2005	5
28	The Cardiac Antihypertrophic Effects of Cyclic GMP-Generating Agents: An Experimental Framework for Novel Treatments of Left Ventricular Remodeling	Vascular Disease Prevention	2005	5
29	The GNAS 393 T > C Polymorphism and the Blood Pressure Response Immediately Following Aerobic Exercise Among Men with Elevated Blood Pressure	Vascular Disease Prevention	2009	5
30	Genetic Polymorphisms of Type-1 and Type-2 Inflammatory Cytokines in Ischaemic Stroke	Vascular Disease Prevention	2008	4
31	Viewing the Cardiovascular Pathogenicity of Lp(a) from the Pro-Inflammatory Side	Vascular Disease Prevention	2008	4
32	Circadian Variation of Cardiovascular Events and Morning Blood Pressure Surge	Vascular Disease Prevention	2008	4
33	Systemic Inflammation Induces Endothelial Dysfunction in Peritoneal Dialysis Patients	Vascular Disease Prevention	2007	3
34	Asymmetric Dimethylarginine (ADMA) and Cardiovascular Disease	Vascular Disease Prevention	2008	3
35	Diagnosis of Vulnerable Plaque and Vulnerable Patient by Coronary Angioscopy and Multi-detector Row Computed Tomography (MDCT) - From Invasive to Non-invasive Plaque Imaging	Vascular Disease Prevention	2008	3
36	Apolipoprotein(a) in the Carotid Artery Plaque: Evidence for Proteolytic and Pro-Inflammatory Modifications	Vascular Disease Prevention	2008	3
37	Clinical Resolution of Type 2 Diabetes with Reduction in Body Mass Index Using Meal Replacement Based Weight Loss	Vascular Disease Prevention	2008	3
38	The Influence of Erythropoietin and Proinflammatory Cytokines in the Development of Cerebral Palsy	Vascular Disease Prevention	2008	3
39	Assessment of Autonomic Function Activity in Obese Children	Vascular Disease Prevention	2009	3
40	Neutrophil Cell Count is Related to Hypertension in Workers: A Cross- Sectional Study	Vascular Disease Prevention	2007	3
41	Blocking Leukocyte Rolling: Does it have a Role in Disease Prevention?	Vascular Disease Prevention	2004	3
42	Characterizing Blood Pressure, Heart Rate, Physical Activity, Circadian Rhythm and their Response to NOS Inhibitor and Substrate in CHF Rats with Telemetry	Vascular Disease Prevention	2004	3
43	Interaction Between Platelets and Cytokines - A Possible Role in the Pathogenesis of Preeclampsia	Vascular Disease Prevention	2004	3
44	Atherosclerotic Plaque Stabilization - Potential Role for Immunomodulatory Therapy	Vascular Disease Prevention	2004	3
45	Nitric Oxide in Cardiac Transplantation	Vascular Disease Prevention	2005	3
46	The Molecular Basis of the Interplay between Endothelin-1 and Nitric Oxide and its Relevance for Atherosclerosis and Arterial and Pulmonary Hypertension	Vascular Disease Prevention	2005	3
47	58-Year Old Men with Non-Stenotic Carotid Artery Plaques and the Relationship with Cardiovascular Risk Factors and Future Cardiovascular Events	Vascular Disease Prevention	2005	3
48	Early, Intensive and Long-term Statin Therapy in Acute Coronary Syndrome: Focus on Anti-inflammatory Mechanisms	Vascular Disease Prevention	2005	3
49	Human Urotensin II and Metabolic Syndrome	Vascular Disease Prevention	2006	3
50	Fibrin Clot Properties and Cardiovascular Disease	Vascular Disease Prevention	2008	3

Scientometrics

Overviews

Citing Bodies

Vascular Disease Prevention

Top Articles